Skip to main content
Contact Us
Subscribe
E-Edition
72°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about jnj
Recent news which mentions jnj
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
In-Depth Analysis: Johnson & Johnson Versus Competitors In Pharmaceuticals Industry
Today 11:00 EDT
Tickers
JNJ
NEWS
Tags
News
JNJ
Benzinga
From
Benzinga
Why Masimo Stock Crushed the Market Today
September 25, 2024
Tickers
JNJ
KFY
MASI
Tags
KFY
Recent Press Releases
Market News
From
Motley Fool
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff
September 25, 2024
Tickers
GS
GSK
HLN
JNJ
Tags
Media
KVUE
Rumors
From
Benzinga
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
September 25, 2024
Tickers
ABT
JNJ
Tags
JNJ
ABT
Market News
From
Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
September 23, 2024
Tickers
BHVN
BMY
BNTX
CI
Tags
TGTX
CI
MNKD
From
Benzinga
Is Johnson & Johnson Stock a Buy?
September 21, 2024
Tickers
JNJ
Tags
JNJ
Recent Press Releases
Market News
From
Motley Fool
Johnson & Johnson's Rybrevant Scores Third FDA-Approval Of 2024 For Certain Type Of Inoperable Lung Cancer In Pretreated Patients
September 20, 2024
Tickers
JNJ
NEWS
Tags
Market News
News
Large Cap
From
Benzinga
Zevra Therapeutics' Drug Becomes First FDA-Approved Treatment For Ultra-Rare Neurodegenerative Disease
September 20, 2024
Tickers
JNJ
NEWS
ZVRA
Tags
Top Stories
Health Care
JNJ
From
Benzinga
The Latest Analyst Ratings For Johnson & Johnson
September 19, 2024
Tickers
JNJ
Tags
Analyst Ratings
BZI/AAR
Benzinga
From
Benzinga
2 Vanguard Index Funds Could Turn $400 Per Month Into $16,800 in Annual Dividend Income by Retirement
September 19, 2024
Tickers
AAPL
AMZN
AVGO
GOOG
Tags
JNJ
MSFT
GOOG
From
Motley Fool
Chinese Biotech BeiGene Labeled 'Unique Investment' As Analyst Confident In Lead Cancer Drug
September 18, 2024
Tickers
AZN
BGNE
JNJ
NEWS
Tags
Expert Ideas
Price Target
Briefs
From
Benzinga
Should You Buy Novavax Stock After This Regulatory Win?
September 13, 2024
Tickers
BNTX
JNJ
MRNA
NVAX
Tags
SNY
PFE
Recent Press Releases
From
Motley Fool
Unpacking the Latest Options Trading Trends in Johnson & Johnson
September 12, 2024
Tickers
JNJ
Tags
BZI/UOA
Benzinga
Options
From
Benzinga
Competitor Analysis: Evaluating Johnson & Johnson And Competitors In Pharmaceuticals Industry
September 12, 2024
Tickers
JNJ
NEWS
Tags
News
JNJ
Benzinga
From
Benzinga
How To Earn $500 A Month From Johnson & Johnson Stock
September 12, 2024
Tickers
JNJ
NEWS
Tags
Market News
Markets
News
From
Benzinga
Metals in Tampons: FDA Initiates New Safety Measures and Testing
September 11, 2024
Tickers
EPC
JNJ
KMB
NEWS
Tags
News
EPC
KMB
From
Benzinga
Sony Music-Universal Music JV Hits Johnson & Johnson With Copyright Lawsuit Over Unlicensed Music Use Covering 80 Videos
September 11, 2024
Tickers
JNJ
NEWS
Tags
Health Care
JNJ
AI Generated
From
Benzinga
Johnson & Johnson's Mid-Stage Lung Cancer Trial Reveals Fewer Infusion-Related Reactions
September 11, 2024
Tickers
JNJ
NEWS
Tags
Top Stories
JNJ
Health Care
From
Benzinga
Is Hims & Hers Health the Next Teladoc?
September 11, 2024
Tickers
HIMS
JNJ
LLY
MRNA
Tags
HIMS
Market News
MRNA
From
Motley Fool
2 Stocks That Are Passive Income Machines to Buy and Hold Forever
September 11, 2024
Tickers
ABT
JNJ
Tags
Recent Press Releases
Market News
ABT
From
Motley Fool
Protagonist Therapeutics' Two Investigational Candidates Target Over $10B Market, Bullish Analyst Opines
September 10, 2024
Tickers
JNJ
NEWS
PTGX
TAK
Tags
Analyst Color
Market News
Analyst Ratings
From
Benzinga
Kenvue Set To Pop Like A Tylenol Gelcap? Golden Cross Looms On Stock Chart
September 10, 2024
Tickers
JNJ
KVUE
Tags
Stories That Matter
Benzinga
Long Ideas
From
Benzinga
Dell, CoStar, PayPal And A Major Health Care Stock On CNBC's 'Final Trades'
September 06, 2024
Tickers
AAPL
CSGP
DELL
JNJ
Tags
Market News
Halftime Report Final Trades
Markets
From
Benzinga
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
September 06, 2024
Tickers
CVS
JNJ
NEWS
PDCO
Tags
Pre/Market Outlook
Trading Ideas
JNJ
From
Benzinga
Johnson & Johnson Raises Talc Settlement Offer to $9B, Moves Closer to Settlement Victory
September 05, 2024
Tickers
JNJ
NEWS
Tags
Biotech
Benzinga
Stories That Matter
From
Benzinga
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
September 05, 2024
Tickers
ABBV
ATAI
CMPS
COMP
Tags
Market News
Cannabis
Compass Pathways
From
Benzinga
2 Dividend Stocks With Payouts That May Not Be as Safe as They Seem
September 05, 2024
Tickers
INTC
JNJ
MO
WBA
Tags
MO
INTC
WBA
From
Motley Fool
Court Orders Johnson & Johnson To Compensate Auris Health Shareholders $1B
September 04, 2024
Tickers
JNJ
NEWS
Tags
Briefs
Biotech
Benzinga
From
Benzinga
3 Dividend Stocks to Double Up on Right Now
September 04, 2024
Tickers
JNJ
NKE
VZ
Tags
VZ
Market News
Recent Press Releases
From
Motley Fool
Despite Medicare Negotiations, Americans May Still Have To Pay More For Prescription Drugs
September 03, 2024
Tickers
AMGN
AZN
BMY
JNJ
Tags
Biotech
Benzinga
Stories That Matter
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.